Clay B. Siegall - 05 Aug 2021 Form 4 Insider Report for Seagen Inc.

Signature
By: /s/ Elizabeth Bekiroglu For: Clay B. Siegall
Issuer symbol
N/A
Transactions as of
05 Aug 2021
Net transactions value
-$4,313,422
Form type
4
Filing time
06 Aug 2021, 20:28:56 UTC
Previous filing
06 Jul 2021
Next filing
18 Aug 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGEN Common Stock Options Exercise $35,558 +2,300 +0.32% $15.46* 717,509 05 Aug 2021 Direct F1
transaction SGEN Common Stock Sale $378,971 -2,300 -0.32% $164.77 715,209 05 Aug 2021 Direct F1, F2, F3
transaction SGEN Common Stock Options Exercise $74,409 +4,813 +0.67% $15.46* 720,022 05 Aug 2021 Direct F1
transaction SGEN Common Stock Sale $788,369 -4,813 -0.67% $163.80 715,209 05 Aug 2021 Direct F1, F2, F4
transaction SGEN Common Stock Options Exercise $143,191 +9,262 +1.3% $15.46* 724,471 05 Aug 2021 Direct F1
transaction SGEN Common Stock Sale $1,510,632 -9,262 -1.3% $163.10 715,209 05 Aug 2021 Direct F1, F2, F5
transaction SGEN Common Stock Options Exercise $111,080 +7,185 +1% $15.46* 722,394 05 Aug 2021 Direct F1
transaction SGEN Common Stock Sale $1,164,114 -7,185 -0.99% $162.02 715,209 05 Aug 2021 Direct F1, F2, F6
transaction SGEN Common Stock Options Exercise $32,729 +2,117 +0.3% $15.46* 717,326 06 Aug 2021 Direct F1
transaction SGEN Common Stock Sale $339,694 -2,117 -0.3% $160.46 715,209 06 Aug 2021 Direct F1, F2, F7
transaction SGEN Common Stock Options Exercise $56,831 +3,676 +0.51% $15.46* 718,885 06 Aug 2021 Direct F1
transaction SGEN Common Stock Sale $585,440 -3,676 -0.51% $159.26 715,209 06 Aug 2021 Direct F1, F2, F8

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SGEN Non-Qualified Stock Option (right to buy) Options Exercise $0 -2,300 -7.8% $0.000000 27,053 05 Aug 2021 Common Stock 2,300 $15.46 Direct F9
transaction SGEN Non-Qualified Stock Option (right to buy) Options Exercise $0 -4,813 -18% $0.000000 22,240 05 Aug 2021 Common Stock 4,813 $15.46 Direct F9
transaction SGEN Non-Qualified Stock Option (right to buy) Options Exercise $0 -9,262 -42% $0.000000 12,978 05 Aug 2021 Common Stock 9,262 $15.46 Direct F9
transaction SGEN Non-Qualified Stock Option (right to buy) Options Exercise $0 -7,185 -55% $0.000000 5,793 05 Aug 2021 Common Stock 7,185 $15.46 Direct F9
transaction SGEN Non-Qualified Stock Option (right to buy) Options Exercise $0 -2,117 -37% $0.000000 3,676 06 Aug 2021 Common Stock 2,117 $15.46 Direct F9
transaction SGEN Non-Qualified Stock Option (right to buy) Options Exercise $0 -3,676 -100% $0.000000* 0 06 Aug 2021 Common Stock 3,676 $15.46 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F3 Reflects sales of common stock executed in multiple transactions at prices ranging from $164.57 to $164.98. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F4 Reflects sales of common stock executed in multiple transactions at prices ranging from $163.46 to $164.45. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F5 Reflects sales of common stock executed in multiple transactions at prices ranging from $162.46 to $163.45. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F6 Reflects sales of common stock executed in multiple transactions at prices ranging from $161.45 to $162.44. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F7 Reflects sales of common stock executed in multiple transactions at prices ranging from $160.01 to $160.98. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F8 Reflects sales of common stock executed in multiple transactions at prices ranging from $158.78 to $159.65. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F9 Options vested at a rate of 25% on 8/24/12 and monthly thereafter until all the options were fully vested on 8/24/15.